OR WAIT null SECS
November 29, 2021
Novozymes and Novo Nordisk Pharmatech are teaming up to develop best-in-class technical enzymes to support biopharmaceutical production processes.
BeiGene has acquired property in Hopewell, NJ to build a new manufacturing site and clinical R&D center for advanced new medicines.
Samsung Biologics, GreenLight Biosciences, and Environmental Impact Acquisition Corp. have partnered to advance GreenLight’s mRNA COVID-19 vaccine candidate.
Donaldson Company's acquisition of Solaris Biotechnology is intended to expand their footprint in the life sciences market.
November 26, 2021
Benchling raised $100 million to expand in Europe and further develop it's cloud-based R&D platform.
November 19, 2021
Novo Nordisk’s 3.3 billion acquisition of Dicerna gives them access to their RNAi technology.
Secarna Pharmaceuticals and Achilles Therapeutics have entered into an agreement to optimize the development of T cell therapies in Achilles’ pipeline.
CGT Catapult and Deep Science Ventures have partnered to encourage innovative approaches to overcoming barriers in delivering advance therapies to patients.
November 18, 2021
Lonza is expanding its microbial development capabilities at its Visp, Switzerland, site to support clinical and commercial drug development programs.
Leading legislators have launched the campaign to enact a second version of the 21st Century Cures Act.